This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Financial advisors offer valuable recommendations for new investors. Learn their insights to enhance your investment approach.
28,363 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
Tower Semiconductor stock jumped today after a strategic move into AI networking. This article breaks down the deal, ...
Amentum faces a pivotal Q2 2026 earnings season. This deep dive breaks down backlog, margins, and guidance, with prac...
Qualcomm sits at the intersection of 5G, auto tech, and AI. This article explores the key catalysts that could send t...
When Space Force makes obvious moves to pause launches from Boeing and Lockheed's space venture, investors face a tes...
Sandisk has become a hot topic for investors watching big moves in AI storage. This guide breaks down what a stock sp...
Costco just signed massive Florida land deal signals a bold expansion move. This article breaks down what it means fo...
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
EOS Energy sparked a fresh rally by expanding into Europe and reporting a production milestone. This article explains...
As Disney readies Toy Story 5, investors wonder if this beloved IP can spark a broader upswing. This piece breaks dow...